Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|June 12, 2002
Chalcones and flavonoids as anti-tuberculosis agentsYuh-Meei Lin, Yasheen Zhou, Michael T Flavin, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitorsChristopher M McBride, Paul A Renhowe, Thomas G Gesner, et al.
ACS Chemical Biology|June 24, 2020
Inhibiting Protein Prenylation with Benzoxaboroles to Target Fungal Plant PathogensSang Hu Kim, Chunliang Liu, Yasheen Zhou, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 21, 2012
Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agentsDavid E Zembower, Yongping Xie, Ali Koohang, et al.
Bioorganic & Medicinal Chemistry|July 25, 2003
Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)--diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketonesJian Cui, David Crich, Donald Wink, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2013
Linking phenotype to kinase: identification of a novel benzoxaborole hinge-binding motif for kinase inhibition and development of high-potency rho kinase inhibitorsTsutomu Akama, Chen Dong, Charlotte Virtucio, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosisAaron Korkegian, Theresa O'Malley, Yi Xia, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2016
Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture ChangesChen Dong, Charlotte Virtucio, Olga Zemska, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinoloneXianfeng Li, Yong-Kang Zhang, Jacob J Plattner, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2006
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studiesXiaodong Lin, Jeremy M Murray, Alice C Rico, et al.
Pageof 4